Log In
    News

    HMNC Brain Health Scheduled to Present at NobleCon18 Investor Conference

    4/6/2022
    Health
    0 min read

    HMNC Brain Health CFO Nir Naor provides a preview of their upcoming presentation at NobleCon18

    NobleCon18 – Noble Capital Markets 18th Annual Small and Microcap Investor Conference – April 19-21, 2022 – Hard Rock, Hollywood, FL 100+ Public Company Presentations | Scheduled Breakouts | Panel Presentations | High-Profile Keynotes | Educational Sessions | Receptions & Networking Events

    Free Registration Available – More Info


    Learn more about HMNC


    NobleCon18 Presenting Companies

    About HMNC Brain Health

    HMNC Brain Health is a disruptive clinical stage biopharma company pioneering Precision Psychiatry, powered by its AI Platform, and focusing on Treatment-Resistant Depression (TRD) and Major Depressive Disorder (MDD). HMNC Brain Health uses its AI Platform, combining Psychiatry, Genomics, and Analytics, to develop innovative therapies for mental health disorders.
    Share
    Related News
    ‌
    Fed Stays on Track for September Rate Cut Despite Higher Core Inflation
    8/29/2025
    Uncategorized

    Fed Stays on Track for September Rate Cut Despite Higher Core Inflation

    The Federal Reserve’s preferred inflation measure, the Personal Consumption Expenditures (PCE) Price Index, showed a modest uptick in July but is unlikely to derail expectations for an interest rate cut...
    3 min read
    ‌
    Release – Vince Announces Reporting Date for Second Quarter 2025 Financial Results
    8/29/2025
    Retail and Consumer

    Release – Vince Announces Reporting Date for Second Quarter 2025 Financial Results

    Vince Holding Corp., (NYSE: VNCE) (“VNCE” or the “Company”), a global contemporary retailer, today announced that it plans to report its second quarter 2025 financial results post-market on Wednesday, September...
    2 min read
    ‌
    Release – MustGrow Closes Non-Brokered LIFE Offering of Approximately $2.1 Million, Repricing of Warrants, and Shares for Debt Settlement 
    8/29/2025
    Health

    Release – MustGrow Closes Non-Brokered LIFE Offering of Approximately $2.1 Million, Repricing of Warrants, and Shares for Debt Settlement 

    MustGrow Biologics Corp. (TSXV: MGRO; OTC: MGROF; FRA: 0C0) (the “Company” or “MustGrow”), is pleased to announce: (i) the closing of its previously annoucned non-brokered private placement of 3,059,731 units of...
    8 min read
    ‌
    Lucky Strike Entertainment (LUCK) – Throws A Curve Ball, But Delivers A Strike!
    8/29/2025
    Consumer

    Lucky Strike Entertainment (LUCK) – Throws A Curve Ball, But Delivers A Strike!

    A solid finish to the year. The company beat our fiscal Q4 revenue and adj. EBITDA estimates, culminating in a transitional fiscal full year 2025 with improving revenue trends. Total Q4...
    2 min read

    Inbox Intel from Channelchek.

    Informed investors make more money. And it’s all about timing. Get it when it happens.

    By clicking submit you are agreeing to the Terms of Use and Privacy Policy
    Log In